acp endorsement
Benefit Managers Brace: Semaglutide Coverage Rises 35% Rapidly
35% of health insurers accelerated semaglutide coverage within eight months of the ACP endorsement, making the drug a new standard for first-line obesity therapy. The American College of Physicians' 2023 endorsement sparked rapid policy shifts, prompting carriers to move from restrictive stop-light tiers to automatic acceptance. Medical Disclaimer: This